Literature DB >> 18412808

Bullous systemic lupus erythematosus responding to dapsone.

Mathew W Ludgate1, Deborah E Greig.   

Abstract

A 29-year-old woman with a 4-week history of systemic lupus erythematosus presented acutely with a severe generalized tense vesicular and bullous eruption with involvement of mucosal surfaces. At the time of her initial diagnosis of systemic lupus erythematosus, she had declined treatment, preferring to explore complementary medical therapies. Skin biopsy showed subepidermal blister formation with inflammation at the dermoepidermal junction. Direct immunofluorescence revealed strongly positive linear deposition of IgG and IgM, and positive linear granular deposition of IgA along the basement membrane zone. Electron microscopy showed that the level of the basement membrane split was below the lamina densa. A diagnosis of bullous systemic lupus erythematosus was made and dapsone was commenced, with a dramatic improvement in her skin eruption. The patient again declined further treatment of her systemic disease and sought complementary therapies, and subsequently presented with cerebral involvement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18412808     DOI: 10.1111/j.1440-0960.2008.00437.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  7 in total

1.  Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument.

Authors:  Rachel S Klein; Pamela A Morganroth; Victoria P Werth
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

Review 2.  Dapsone in the management of autoimmune bullous diseases.

Authors:  Evan W Piette; Victoria P Werth
Journal:  Dermatol Clin       Date:  2011-10       Impact factor: 3.478

Review 3.  [Dermatological symptoms in rheumatology].

Authors:  E Aberer
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

Review 4.  Dapsone in the management of autoimmune bullous diseases.

Authors:  Evan W Piette; Victoria P Werth
Journal:  Immunol Allergy Clin North Am       Date:  2012-04-18       Impact factor: 3.479

5.  Dapsone as an alternative therapy in children with familial mediterranean Fever.

Authors:  Farhad Salehzadeh; Sepideh Jahangiri; Elnaz Mohammadi
Journal:  Iran J Pediatr       Date:  2012-03       Impact factor: 0.364

Review 6.  Treatment of Bullous Systemic Lupus Erythematosus.

Authors:  Lihua Duan; Liying Chen; Shan Zhong; Ying Wang; Yan Huang; Yan He; Jie Chen; Guixiu Shi
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

7.  Lupus erythematosus and neutrophilic urticarial dermatosis: a retrospective study of 7 patients.

Authors:  Laurence Gusdorf; Didier Bessis; Dan Lipsker
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.